Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,580Revenue (TTM) $M44.8Net Margin (%)-864.0Altman Z-Score19.3
Enterprise Value $M7,986EPS (TTM) $-8.2Operating Margin %-827.1Piotroski F-Score5
P/E(ttm)--Beneish M-Score121Pre-tax Margin (%)-860.7Higher ROA y-yN
Price/Book14.110-y EBITDA Growth Rate %--Quick Ratio10.4Cash flow > EarningsY
Price/Sales1675-y EBITDA Growth Rate %-13.9Current Ratio10.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-77.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-126.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M53.6ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with TSRO

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

TSRO is held by these investors:



TSRO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
English Edward CV.P. of Finance & Admin. 2017-03-06Sell10,000$178.06-10.14view
PEARSON TIMOTHY RExec. VP, CFO 2017-03-02Sell1,447$177.61-9.91view
Oliveira OrlandoSVP & GM, International 2017-03-02Sell249$177.61-9.91view
Huber Martin H. Jr.Sr. VP, Chief Medical Officer 2017-03-02Sell1,428$177.61-9.91view
Hedley Mary LynnePresident & COO 2017-03-02Sell3,927$177.61-9.91view
Farmer Joseph LSr VP,Gen. Counsel & Secretary 2017-03-02Sell1,449$177.61-9.91view
English Edward CVP of Finance & Administration 2017-03-02Sell229$177.61-9.91view
Bogle Grant C.Sr VP,Chief Commercial Officer 2017-03-02Sell1,447$177.61-9.91view
Huber Martin H. Jr.SVP & Chief Medical Officer 2017-01-03Sell190$136.2617.42view
English Edward CVP of Finance and Admin. 2016-12-12Sell10,000$129.0523.98view

Press Releases about TSRO :

Quarterly/Annual Reports about TSRO:

News about TSRO:

Articles On GuruFocus.com
Andreas Halvorsen Buys Maker of First-in-Class Cancer Treatments, Calithera Biosciences Feb 22 2017 
7 Stocks Outperforming the Market Jan 12 2017 
Steven Cohen's Assets With Highest Returns Dec 30 2016 
A Tesaro Catalyst the Markets Seem to Have Overlooked Dec 20 2016 
Pioneer Investments Continues to Buy Alibaba, 8 Others Dec 07 2016 
Major Second Quarter Purchases for Cohen include Tesaro, Pernix Jul 20 2016 
Steven Cohen Hits Another Home Run in Oncology Jul 07 2016 
David Swensen Bets on Antero Resources Mar 10 2016 
David Swensen's Transactions Show Diversity of Portfolio Nov 19 2015 

More From Other Websites
AstraZeneca PLC (ADR) (AZN)’s Lynparza Trial Results Positive In Competitive Threat To Clovis... Mar 16 2017
Tesaro Sell-Off On AstraZeneca Ovarian Cancer Trial Overdone: Analyst Mar 15 2017
Here’s What Just Happened With AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO) And Clovis Oncology... Mar 15 2017
AstraZeneca Ovarian Cancer Drug Succeeds in Trial Mar 15 2017
Lynparza Vs. Niraparib Mar 15 2017
Wedbush Cuts TESARO Target By 18% Following SOLO-2 Results Mar 15 2017
Why Tesaro is Tanking Mar 14 2017
AstraZeneca ovarian cancer drug slows disease markedly in study Mar 14 2017
AstraZeneca ovarian cancer drug slows disease markedly in study Mar 14 2017
Tesaro Announces Presentation of Niraparib Phase 3 ENGOT-OV16/NOVA Trial Secondary Endpoint Results... Mar 13 2017
TESARO Announces Niraparib Data Presentations at the 2017 SGO Annual Meeting on Women’s Cancer Mar 12 2017
Blog Coverage CEL-SCI Provides Update on Late-stage Multikine Head and Neck Cancer Study Mar 08 2017
TESARO, Inc. :TSRO-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017 Mar 06 2017
TESARO, INC. Financials Mar 04 2017
TESARO, Inc. :TSRO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017 Mar 03 2017
Tesaro Shares Could Jump On A Buyout Offer Mar 02 2017
Do Options Traders Know Something About Tesaro (TSRO) Stock We Don't? Mar 02 2017
Tesaro Eyes Immuno-Oncology As AstraZeneca, Clovis Loom: Analyst Mar 01 2017
Edited Transcript of TSRO earnings conference call or presentation 28-Feb-17 9:15pm GMT Feb 28 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)